Follow-The-Filings

Security · featured owners

CHE Chemed Corp. New

Health Care COM Equity among managers we track

CHE (Chemed Corp. New) 13F ownership among featured managers we track. Figures are as-filed 13F, not free float.

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

SEC filings

Recent issuer filings from EDGAR · 10 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q
8-K 2.02,9.01
8-K 5.07
10-Q
8-K 2.02,9.01
8-K 1.01,2.03,9.01
10-K FORM 10-K
8-K 2.02,9.01
10-Q
8-K 2.02,9.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 13 rows shown

Filed Form Detail Links
4 Period Aug 21, 2026 · 2 forms
4 Period Aug 10, 2026
4 Period Aug 5, 2026
4 Period Jul 31, 2026
4 Period Jul 31, 2026
4 Period Jun 9, 2026
4 Period May 29, 2026
4 Period May 18, 2026 · 7 forms
4 Period May 8, 2026
4 Period May 1, 2026
4 Period Mar 27, 2026
4 Period Mar 12, 2026
4 Period Feb 13, 2026 · 6 forms

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $1.32B $1.53B
Net income $272.51M $302M $265.24M
Net margin * 20.7% 19.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $500.84M $394.75M $302.62M
Total non-current assets * $1.17B $1.27B $1.24B
Total assets $1.67B $1.67B $1.54B
Total current liabilities $312.05M $285.7M $287.13M
Total non-current liabilities * $248.17M $263.89M $271.65M
Total equity $1.11B $1.12B $0.979B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $330.3M $417.5M $388.27M
Cash from investing -$60.64M -$143.91M -$59.34M
Cash from financing -$79.82M -$359.19M -$432.77M
Net change in cash * $189.83M -$85.61M -$103.84M

ownership over time

filing count by report period · click a bar for that quarter’s holders